
QVQ Holding B.V.
Utrecht, Netherlands qvquality.com From their website, Nov 2026
Work here? Claim this listing
About
QVQ provides single-domain antibody discovery, engineering, production, purification, characterization, and functionalization services. It serves research customers working with VHH/sdAbs from its site in Utrecht, the Netherlands.
Services
Lead panel discovery
Designs and runs sdAb lead discovery projects including llama immunization, phage-display library construction, panning, screening, and delivery of clones and sequences.
sdAb production & purification
Produces recombinant sdAbs and sdAb fusion molecules in E. coli, yeast, or mammalian cells and purifies them by affinity methods.
Protein production
Biophysical characterization
Performs quality control and characterization of sdAbs by UV-Vis spectroscopy, SDS-PAGE, SEC, and partner-supported methods such as DLS, AC-SINS, HIC, CE-SDS, and intact mass spectrometry.
sdAb pharmacology
Evaluates sdAb function with binding, target engagement, protein-protein interaction, localization, internalization, cell viability, signaling, and immune cell activation assays.
Functionalization
Adds tags, labels, and conjugations to sdAbs, including fluorophores, chelators, HRP, biotin, peptides, oligos, and DBCO linkers.
Engineering
Engineers sdAbs for humanization, protein A binding, thermostability, and affinity maturation, and can generate multivalent or multispecific constructs.
Computational Biology
Provides computational support as part of the stated service menu for sdAb development.
- Turnaround
- 3-4 months
- Within a few months
- What to send
- Recombinant proteins
- Cells
- Other complex antigens
- sdAb of choice
Capabilities
- Assays and studies
- Antibodies
- ELISA
- E. coli expression
- SPR
- CHO
- Peptides
14 more
- Surface plasmon resonance
- BRET
- UV-Vis spectroscopy
- SDS-PAGE
- Size-exclusion chromatography
- Dynamic Light Scattering
- AC-SINS
- Hydrophobic interaction chromatography
- CE-SDS
- Intact protein mass spectrometry
- Cell viability assays
- Cellular signaling assays
- Target engagement assays
- Protein-protein interaction assays
- Scale and capacity
- 2 animals in a 43-day program
- 96-wells format
- E. coli (< 10 mg)
- S. cerevisiae (< 1 g)
- Therapeutic areas
- HIV
- HER2
Instruments and platforms
- Fiber-optic-based SPR setup
Modalities and species
- Modalities
- Antibody
- Bispecific
- Peptide
- Oligonucleotide
- Recombinant protein
- Species and models
- Llama
- E. coli
- Saccharomyces cerevisiae
- ExpiHEK
- CHO-K1
- HEK293T
Industries served
- Research
Details
- Type
- CRO
- Quality
- Animal welfare act (llama immunizations) · animal experiment commission review (llama immunizations)
- Address
- Universiteitsweg 101 3584CG Utrecht © Copyright - QVQ 2025 - All right reserved
- Phone
- +31 (0)30 - 20 85 001